DistantNews
Support us
๐Ÿ‡บ๐Ÿ‡ฌ Uganda /Health & Science

Uganda's Inhaler Gap Leaves Asthma Patients Exposed

From AllAfrica Uganda · () English

Summarized and contextualized by DistantNews.

At a glance

News Named sources Context piece
  • Thousands of asthma patients in Uganda lack access to essential inhalers, despite global shifts towards preventive care.
  • Health specialists warn that Uganda's healthcare system remains focused on emergency treatment rather than long-term disease control, leading to a cycle of severe attacks and preventable deaths.
  • Global guidelines now emphasize anti-inflammatory treatments (inhaled corticosteroids) over reliever medication alone, a shift not yet fully reflected in Uganda.

Uganda is facing a critical public health challenge as a significant portion of its population struggles with asthma, a condition that is increasingly being managed with preventive care globally. The stark reality on the ground, however, is that thousands of Ugandans are still unable to access essential inhalers, a gap that health specialists warn is becoming impossible to ignore.

This issue was brought into sharp focus during World Asthma Day, with this year's theme, "Make inhaled treatments accessible for all," highlighting the profound inequalities in diagnosis and treatment, particularly in low- and middle-income countries like Uganda. Clinicians and researchers have pointed to a persistent disconnect between recommended global treatment guidelines and the actual availability of care in Ugandan health facilities. The current system's heavy reliance on emergency treatments, rather than sustained, long-term disease control, traps patients in a dangerous cycle of repeated attacks, frequent hospitalizations, and, tragically, preventable deaths.

Asthma is responsible for more than 450,000 deaths globally every year, many of which are preventable.

โ€” Dr Charles OlaroDirector General of Health Services at the Ministry of Health, highlighting the global impact of asthma.

Globally, asthma management has undergone a significant transformation over the last decade. The older approach, which prioritized quick-relief bronchodilators, has largely been superseded by anti-inflammatory treatments using inhaled corticosteroids (ICS). This paradigm shift is rooted in a deeper understanding of asthma as a chronic inflammatory condition, not merely a temporary breathing difficulty. Specialists emphasize that without addressing the underlying inflammation, patients remain vulnerable to severe exacerbations, even when symptoms seem mild. Dr. Patricia Alupo underscored this point, stating that current global guidelines no longer support the use of reliever medication as a sole treatment, stressing that no patient should be prescribed treatment without inhaled corticosteroids.

Dr. Charles Olaro, Director General of Health Services at the Ministry of Health, acknowledged asthma as a growing public health concern in Uganda, noting that approximately 11% of the population is affected, including a disproportionately high number of adolescents and young children. While the World Health Organization estimates that asthma affects 262 million people worldwide, the burden is most acute in nations where access to diagnosis and essential medicines is limited. Uganda exemplifies this challenge, where the gap between international best practices and local realities leaves many asthma patients exposed and at risk.

No patient should be prescribed treatment without inhaled corticosteroids.

โ€” Dr Patricia AlupoA physician and respiratory researcher, emphasizing the importance of anti-inflammatory treatment based on current global guidelines.
DistantNews Editorial

Originally published by AllAfrica Uganda. Summarized and contextualized by our editorial team with added local perspective. Read our editorial standards.